Home icon

Accelerate drug discovery with NVIDIA BioNeMo Framework on Amazon EKS

HPC Blog



This article discusses how to accelerate drug discovery using the NVIDIA BioNeMo framework on Amazon EKS (Elastic Kubernetes Service). BioNeMo is a generative AI platform that simplifies and accelerates the training of models for drug discovery tasks like protein structure prediction, de novo design, virtual screening, and property prediction.

Specifically, the article covers:

  • Introduction to NVIDIA BioNeMo and its capabilities for drug discovery
  • Architecture for deploying BioNeMo on Amazon EKS using GPU nodes, Amazon FSx for Lustre file system, and other AWS services
  • Step-by-step guide on setting up the infrastructure using Terraform, preparing data, and running distributed pre-training jobs on BioNeMo
  • Best practices for configuring resources like GPU counts, replicas, and processes per node for efficient parallelization
  • Conclusion highlighting the potential of combining generative AI like BioNeMo with robust cloud infrastructure to accelerate drug discovery


Go to article

The AWS News Feed is currently looking for gold sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.

Related articles

Mar 12
2024
Find the Next Blockbuster with NVIDIA BioNeMo Framework on Amazon SageMaker
Oct 7
2024
Accelerating Drug Discovery with AWS HealthOmics and NVIDIA Blueprints
Apr 19
2024
Scale AI training and inference for drug discovery through Amazon EKS and Karpenter
Mar 18
2024
Protein language model training with NVIDIA BioNeMo framework on AWS ParallelCluster

The AWS News Feed is currently looking for silver sponsors. If you want to support the AWS community and reach a large audience of AWS professionals, consider sponsoring the AWS News Feed.